Remove CFP Remove Manufacturing Remove Portfolio Management
article thumbnail

Charting the Path Ahead: Mid-Year Market Recap and Inflation Outlook

Bell Investment Advisors

I’m joined here today by Ryan Kelley, Lead Portfolio Manager and Research Analyst for Bell. Slide 1: Charting the Path Ahead: Mid-Year Market Recap and Inflation Outlook 0:00 Laurent Harrison: Welcome to today’s webinar, Charting the Path Ahead: Mid-Year Market Recap and Inflation Outlook. 0:17 Ryan Kelley: Thanks.

article thumbnail

Should the CFP Board police financial advisor “bad apples”? The debate continues! (Part Two)

Sara Grillo

In Part Two of our two part series on the CFP Board, the heated debate continues. We’ll discuss these questions: The CFP Board has specifically stated that it wants the CFP® mark to be a requirement for anyone who practices financial planning. What do you believe the CFP Board’s role should be in the future?

CFP
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Should you die and go to hell before selling an annuity?

Sara Grillo

Macchia mentions that there are firms that have sprung up offering no load products, products that report into your portfolio management system, wrap-able products, etc. Mettler is a CFP® certificant (INSERT LINK WHEN AVAIL) and he says that even the CFP Board passed a fiduciary guideline. Are commissions bad?

article thumbnail

Transcript: Savita Subramanian

The Big Picture

They eventually get a CFP and they go to the advisory side. Or, or people start out with a CFA and they decide, you know, I would rather manage the portfolio than tell I’d rather be a PM than advise the pm. Whereas in 1980, 70% of it was manufacturing asset intensive, et cetera. That that works for them.

article thumbnail

Forecasting Follies 2024

The Better Letter

For example, if, say five years ago, you knew that there would be a global pandemic and that Pfizer would be the leading manufacturer of a vaccine to deal with the virus that would generate sales of over $70 billion in 2021-22, I’m guessing you’d eagerly bet that Pfizer would outperform the market. The funniest.

article thumbnail

Transcript: Tony Kim, Blackrock Active Technology

The Big Picture

Barry Ritholtz : This week on the podcast, another extra special guest, Tony Kim, is managing director at BlackRock, where he heads the fundamental equity technology group helping to oversee all of the active technology investments BlackRock makes. I must have worked for 30, 40 portfolio managers across four, four or five investment firms.